This compound is a steroidal pharmaceutical intermediate characterized by a tetracyclic ring system and multiple chiral centers. Its primary significance lies in its use as a building block for the synthesis of specialized steroid derivatives.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 459789-97-0
(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
active pharmaceutical ingredient
(R)-4-((3R,5S,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
active pharmaceutical ingredient
6,7-DIHYDROXY-3,4-DIHYDROISOQUINOLINE
pharmaceutical intermediate
(1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID
Pharmaceutical intermediate for lurasidone
3-hydroxy-2,3-dimethylbutan-2-yl hydrogen (10-phenylanthracen-9-yl)boronate
synthetic intermediate for boron-containing compounds
1,1,1-Trifluoro-4-iodobutane
Pharmaceutical intermediate
3alpha-Hydroxy-7-oxo-5beta-cholan-24-oic acid methyl ester
bile acid intermediate for drug synthesis
7-Ketolithocholic acid
bile acid intermediate
ethyl (4R)-4-[(3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
PRZCLWHVOYRZJL-GAKWKJAJSA-N
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C1=O)CC[C@@H]4[C@H](C)CCC(=O)OCC)C)C)O
—